A multipurpose silicone elastomer vaginal ring releasing dapivirine and Cu2+/Zn2+ ions for HIV prevention and non-hormonal contraception
A dapivirine (DPV)-releasing vaginal ring (DapiRing®, containing 25 mg DPV) has been approved in various African countries for prevention of human immunodeficiency virus type 1 (HIV-1). Current research is focused on next-generation multipurpose prevention technology (MPT) vaginal rings that additionally provide contraception, and a combination dapivirine + levonorgestrel ring is in clinical development. However, hormonal contraceptives have numerous side effects and contraindications, and many women are interested in hormone-free contraceptive options. Copper and zinc have well documented spermicidal activity; for example, copper intrauterine devices—comprising a copper metal wire fitted to a polyethylene frame and releasing cupric (Cu2+) ions—have a long history of use as a long-acting reversible non-hormonal form of contraception. Here, we report a multipurpose vaginal ring offering sustained release of DPV, Cu2+ ions, and Zn2+ ions. Matrix-type silicone elastomer vaginal rings containing different combinations of DPV (25 mg) and various copper/zinc substances (copper nanopowders, zinc nanopowders, copper sulphate pentahydrate, and zinc acetate dihydrate) were successfully manufactured by injection molding. DPV and the metal nanopowders were stable during manufacturing; partial dehydration occurred with copper sulphate pentahydrate and zinc acetate dihydrate. Incorporation of copper/zinc substances had minimal impact on DPV release, and the formulations produced similar DPV release compared with DapiRing®. Rings containing metal salts released significantly more Cu2+/Zn2+ ions than those containing metal nanopowders, and greater quantities of Cu2+/Zn2+ ions compared with marketed copper IUDs or experimental copper-zinc IUDs. The results demonstrate that copper/zinc metals and salts can be effectively incorporated into and released from silicone elastomer vaginal rings and are compatible with DPV. The inclusion of copper/zinc offers potential as non-hormonal contraception and warrants further investigation in the context of MPTs.
April 2025
Click for full info +Full Info:
Resource Type:
Journal Article
Journal Article
Resource
Citation:
Authors: Shen, X., Boyd, P., Dallal Bashi, Y.H., McCoy, C.F., Zhao, X., Malcolm, R.K.
Health Risks(s):
- HIV
Product type(s):
- ARVs
- Contraceptives
- IVR
- VaginalInserts
Topic(s):
- MPTs
- Development
Region(s)
- Africa
Additional Keywords:
vaginal ring, HIV prevention, multipurpose prevention technologies (MPTs), non-hormonal contraception